Pfizer's Fast-Acting Nasal Spray for Migraine Treatment Gets Approval From the US FDA
Pfizer has released a statement that their fast-acting nasal spray for migraine treatment has been approved.
Source: techtimes.com
Stay updated with breaking news from Pfizer Pours. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer has released a statement that their fast-acting nasal spray for migraine treatment has been approved.
A pharmaceutical commission allegedly fined Pfizer CEO Albert Bourla for "misleading" comments about the Covid vaccination for kids.
The nasal take on the COVID-19 vaccine did not bode well in its clinical trials. Oxford and AstraZeneca decided to go on a different route to deliver vaccines to patients, and it is through an intranasal shot to administer the protection without using needles.